All Updates

All Updates

icon
Filter
Product updates
Predictive Oncology launches 3D cell culture model for oncology drug discovery
Precision Medicine
Jun 4, 2024
This week:
Funding
Lhyfe receives EUR 11 million grant from Klimatklivet for green hydrogen project in Sweden
Hydrogen Economy
Yesterday
Product updates
XRAI Glass launches AR One glasses at USD 1449 for hearing-impaired individuals
Extended Reality
Yesterday
Funding
VR therapy platform CUREosity raises EUR 3.8 million in funding to expand market presence
Extended Reality
Yesterday
Last week:
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Decentralized Finance (DeFi)
Jun 22, 2024
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Web3 Ecosystem
Jun 22, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Data Infrastructure & Analytics
Jun 21, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Foundation Models
Jun 21, 2024
Partnerships
Product updates
Anthropic releases Claude 3.5 Sonnet, the first model in the 3.5 series
Foundation Models
Jun 21, 2024
Funding
Paramount Planet Product raises USD 1 million in federal grant funding to support commercialization
Bio-based Materials
Jun 21, 2024
Regulation/policy
Apple delays launch of Apple Intelligence features in EU citing regulatory concerns
Generative AI Applications
Jun 21, 2024
Precision Medicine

Precision Medicine

Jun 4, 2024

Predictive Oncology launches 3D cell culture model for oncology drug discovery

Product updates

  • Predictive Oncology has launched its innovative 3D cell culture model, which is aimed to enhance cancer drug discovery, as well as facilitate future drug development. Price details were not disclosed.

  • The 3D cell culture model designed by Predictive Oncology simulates human tissue more accurately than conventional 2D assays. Some of the key features include its organ- and disease-specific design, the ability to replicate the physiological environment of human tissue, and its compatibility with multiple cell types and drug classes. According to Predictive Oncology, this unique model allows for more precise predictions of clinical outcomes and aids in optimizing candidate selection for later clinical development. This could shorten the time it takes for drugs to reach the market, decrease costs, and reduce the necessity for animal testing.

  • Predictive Oncology is a biopharmaceutical company specializing in oncology drug discovery through the application of AI and ML. The company leverages its proprietary biobank, which contains over 150,000 tumor samples, to advance the development of cancer therapies.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.